Skip to content

Validity of the SHD-LESS Scale After ACL Reconstruction

Validity of the SHD-LESS Scale in Detecting Landing Asymmetry and Its Association With Functional Status After ACL Reconstruction.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06829849
Acronym
ACL-LESS
Enrollment
60
Registered
2025-02-17
Start date
2024-03-01
Completion date
2025-11-15
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL Injury, ACL Reconstruction

Brief summary

After anterior cruciate ligament reconstruction (ACL-R), Single Hop for Distance (SHD) performance aids in decision-making, particularly for return-to-sport assessments. However, asymmetrical landing kinematics are common after ACL-R, even with symmetrical performances, and increase the risk of re-injury. To support clinical practice, several qualitative scales have been developed as valid and reliable tools for assessing landing quality. In 2022, Measson et al. adapted the Landing Error Scoring System for use during an SHD task (SHD-LESS scale) and demonstrated its reliability among healthy individuals. The aim of this study is to test the validity of this scale after ACL-R by evaluating its ability to identify asymmetrical landing and characterize differences between the operated and uninjured limb. The second objective is to assess its association with knee muscle strength, functional status and psychological readiness.

Interventions

DIAGNOSTIC_TESTLanding error assessment during a SHD task using the SHD-LESS scale

Participants will perform a 2D-camera-recorded SHD task, with the SHD-LESS scored by two sports medicine physicians. Additional tests include isokinetic muscle testing, as well as functional and psychological status assessments, following standard clinical practice.

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18-40, who have undergone a first ACL reconstruction more than 6 months ago and are being followed in a sports medicine care pathway * Affiliated with a health insurance plan * Information form: Non-objection to the use of data for research purposes

Exclusion criteria

* Previous ligament surgery of the lower limbs prior to ACL reconstruction * Complex ligament injury (lateral ligaments, posterior cruciate ligament) * Recent muscle injuries * History of injury to the uninjured knee * Pregnant woman * Inability to perform a muscular assessment * Postoperative complications (deep vein thrombosis, sepsis, stiffness/arthrofibrosis) * Neurological history with residual effects or taking medication that affects balance/coordination

Design outcomes

Primary

MeasureTime frameDescription
Single Hop for Distance, Landing Error Scoring System (SHD-LESS) scaleOne measurement during the visit at 6 to 12 months after surgeryThe LESS (Landing Error Scoring System) scale is a 13-item tool used to assess landing technique during a hop task.

Secondary

MeasureTime frameDescription
StrengthOne measurement during the visit at 6 to 12 months after surgeryMeasurement of knee extensors and flexors peak strength (in newton.meter, Nm) on isokinetic dynamometer
ACL-RSI questionnaire (Anterior Cruciate Ligament-Return to Sport after Injury)One measurement during the visit at 6 to 12 months after surgeryThe ACL-RSI measures the patient's understanding of his knee. It comprises 12 questions with a score of 1 to 10 for each
International Knee Documentation Committee (IKDC) scoreOne measurement during the visit at 6 to 12 months after surgeryKnee level of function based on patient-reported measures from symptoms to daily activities. The IKDC score includes sections on knee symptoms (7 items), function (2 items), and sports activities (2 items), with scores ranging from 0 (lowest function, highest symptoms) to 100 (highest function, lowest symptoms).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026